pathy, MC may be stimulated by cytokines to express ICAM-1 and the interaction between MC and T cell may develop the immunologic response. So it can be speculated that up-regulated expression of ICAM-1 on MC may be involved in the immunologic injury in IgA nephropathy.
We examined in vitro expression of ICAM-1 on cultured mouse MC after stimulation with mononuclear cell culture supernatant from patients with IgA nephropathy, using a cell ELISA method to investigate the poss ible role of mononuclear cells and their products in the pathogenesis of IgA nephropathy.
Ro le o f M o n o n u c le a r C e lls o f Ig A N e p h r o p a t h y
o n ICA M -1 Ex p r e s s io n in M e s a n g ia l C e lls
T a e -W o n Le e , M . D . , J a i-Ky u n g P a r k , P h . D . , J a e -Hy u n g A h n , M . D . , C h u n -G y o o Ih m , M . D . , M y u n g -J a e Kim , M . D . MGN 3, MPGN 1) . The diagnosis of IgA nephropathy was based on the presence of predominant mesangial immunofluorescent IgA deposits and mesangial and paramesangial electron-dense deposits in renal biopsy specimens. Patients with the clinical and laboratory evidence of hepatic disease, systemic lupus erythematosus, Henoch-Schoenlein nephritis and other systemic diseases were excluded. No patient had infection nor was on corticosteroid or immunosuppressive treatment within at least 1 month of entry into the study. Medical doctors and nurses, matched for age and sex with the patients with IgA nephropathy, were selected as normal controls.
O bj e c t iv e s : T o inv e s t ig at e t he p o s s ib le ro le o f m o no n uc le a r ce lls a n d t he ir p rod u ct s in t he p at h o g e n e s is o f Ig A ne p h ro p at hy , in v it ro e x p re s s io n o f ICA M -1 o n c u lt u re d m o u s e m e s a ng ia l c e ll( M C) w as e x a m ine d af t e r s t im u lat io n w it h m o no n u c le a r c e ll c u lt u re s up e rnat a nt f ro m p at ie nt s w it h Ig A ne p h ro p at hy . M e t h o d s : Pe rip h e ra l b lo o d m o no n uc le a r ce lls ( PB M C) w e re is o lat e d a nd c u lt u re d f ro m 18 p at ie nt s w it h p rim a ry Ig A ne p h ro p at hy , 8 n o rm a l co nt ro ls a nd 5 p at ie nt s w it h no n -Ig A n e p h ro p at hy ( FS G S 1, M G N 3 , M PG N 1) . ICA M -1 e x p re s s io n o n c u lt u re d m o u s e M C by T N F-, IL-1 a nd c u lt u re s up e rna nt s o f PB M C w e re a na ly z e d u s ing a c e ll E LIS A m e t h o d . T he co n ce nt rat io n o f IL-1 a nd T N F-in c u lt u re s up e rnat a nt s w a s m e as u re d by us ing a co m m e rc ia lly av a ila b le ra d io im m u no a s s ay k it .

Re s u lt s : A d d it io n o f h u m a n re co m b ina nt T N Find uce d a n inc re as e d ICA M -1 e x p re s s io n in a d o s e -d e p e nd e nt m a n ne r. T he e x p re s s io n o f ICA M -1 w as f u rt he r inc re as e d af te r co -s t im u lat io n w it h T N F-a nd IL-1 . A d d it io n o f PB M C c u lt u re s up e rnat a nt s int o m o us e M C ind uce d s ig n if ica nt ly h ig he r e x p re s s io n of ICA M -1 by s up e rnat a nt s f ro m t he p at ie nt s w it h Ig A ne p h ro p at hy co m p a re d w it h t hat f ro m no rm a l co nt ro ls . T he c o nc e nt rat io n o f T N Fa nd IL-1 in s up e rnat a nt s f ro m t he p at ie nt s w it h Ig A ne p h ro p at hy w a s s ig n if ic a nt ly h ig he r t h a n t h at f ro m t ho s e w it h no n -Ig A ne p h ro p at hy .
Co nc lus io n : T N F-a nd IL-1 re le as e d f ro m m o no n uc le a r ce lls ind uce d t he up -reg u lat io n o f ICA M -1 e x p re s s io n a nd t h is m ay be re late d t o t he im m u ne p at hog e ne s is of Ig
Pre paration of PBMC culture s upe rnatant Mononuclear cells were isolated by Ficoll-Hypaque density gradient method from heparinized venous blood. The cell suspension recovered at the interface was resuspended in RPMI 1640 at a concentration of 5 10 6 cells/ml. The cells were stimulated with phytohemagglutinin (PHA) (10 /ml) and concanavalin A(Con-A) (10 /ml). The PBMC were cultured at 37 in 5% CO2 for 24 h. At the end of incubation, the supernatant was harvested and stored at -70 until tested.
Pre paration of mesa ngial cell culture Kidneys from 5 normal ICR mice were removed. The cortex was minced Into small pieces and passed through a series of steel sieves. The glomeruli collected through the 75 sieve were rinsed with HBSS and were digested with 1ml type IV collagenase (GIBCO, Grand Is land, N.Y., USA) at 37 for 30 min with s haking. Afte r centrifugation, the pellet was suspended in DMEM a nd plated into a tissue culture flas k conta ining DMEM s upple mented with 20% fetal calf serum, 100U/ml penicillin, 100 /ml streptomycin, 10 /ml insulin and Lglutamine. Afte r three or four passages , no endothelial or epithelia l cells we re seen a nd the cultures cons isted exclus ively of mesa ngial cells . The MC were cha racterized by using phase contrast microscopy and the cells had prominent intrace llular myos in fibrils and we re negative with antibodies (Becton Dickinson, Mountain View, Ca lif., USA) to common le ukocyte a ntige n and factor VIII by immunofluorescent sta ining 9 ) . The cells we re ca pable of growth in D-valine-substituted medium a nd we re not sens itive to puromycin.
Expression of ICAM-1 on cultured mouse mesa ngial ce lls ICAM-I expression by cultured mouse MC was analyzed using a cell ELISA.
MC (5 10 4 ) were seeded into 96 well flat-bottom microtiter plates (Costar, Cambridge,Mass., USA) in 200 of DMEM culture medium and cultured to reach confluency for 48h. When MC were confluent, 100 of culture medium was removed from each well and 100 of the following additives were then added to each well to yield a final volume of 200 /well. Human recombinant TNFand IL-1 (R & D system, Minneapolis, Minn., USA) were used at the concentration of 1, 10, 100 pg/ml and 1, 10, 100, 500 ng/ml, respectively, and the combination of the same concentration of TNFand IL-1 . PBMC culture supernatants from the patients with IgA nephropathy, non-IgA nephropathy, and normal controls were also added to other wells. The cultures were incubated for 24h at 37 in 5% CO2 -air. The cell monolayers were washed twice with DMEM and then fixed with 1% paraformaldehyde for 15 min at room temperature. After washing the fixed monolayer with DMEM 3 times, unbound s ites were blocked with 2% solution BSA diluted in DMEM and incubated at 37 for 1h in 5% C02 . After the blocking solution was removed, a 100 of a 1/200 dilution of the rat mAb to mouse ICAM-1 (Serotec, Kidlington, Oxford, UK) was added to each well and the plates were incubated at 3 7 for 1h. After the culture we lls were washed three times with DMEM, 100 of a 1/200 dilution of the developing a ntibody (goat a nti-rat IgG, phosphatase labeled; Gibco, Gra nd Is land, NY, USA) in 1% BSA-DMEM was added. The plates were then incubated for 1h at 37 in 5% CO2 . The enzyme conjugate was removed and the culture cells we re washed 4 times with DMEM. Then 100 of p-nitrophenyl phosphate s ubstrate were added to each well and the plate was incubated at 37 in 5% C02 . Appropriate controls we re included in each assay. These include medium only, or medium + primary antibody + developing a ntibody + substrate. The plates were read on a Be hring ELISA Processor II (405 nM) (Behring, Germany) usua lly at 30-min interva ls from 30 to 180 min or until maximum (OD) readings were obtained. The data are reported as the mea n S EM OD units from triplicate, we lls at one time point on the linea r portion of the deve lopment (time) curve.
Cytokine assay
The concentration of IL-1 and TNFwere measured by using a commercially available radioimmunoassay kit (Amersham, Bucks ., UK).
Statistical ana lys is
The results are expressed as mean S EM. A oneway analysis of variance (ANOVA), with adjustment of P values for multiple comparisons, was performed to compare overall mean levels between groups. If the ANOVA indicated a significant trend among groups, student s t-test and regression analysis were used to test for differences between two groups. A p-value < 0.05 is interpreted to be significant.
R E S U LT S
Res ponse of ICAM-1 expression on cultured mouse MC in res ponse to recombinant huma n TNFand IL-1 .
The control culture of mouse MC in pure medium demonstrated a weak staining (OD405: 0.2897 0.00430), which was not changed after the addition of mouse ICAM-1 mAb, developing antibody and p-nitrophenylphosphate s ubstrate.
Addition of human recombina nt TNFinduced a n increased ICAM-1 expression. It was apparent at the concentration of 1 pg/ml (0.2957 0.0070) and reached a plateau at 100 ng/ml (0.9640 0.0193). Dose response curves for TNFshowed that ICAM-1 express ion is dose-depe nde nt between 1pg and 100 ng/ml (Fig. 1) . Induction of the ICAM-1 expression after stimulation with IL-1 was also dose-dependent a nd was apparent at the conce ntration of 1 pg/ml (0.3017 0.0113) a nd it reached a platea u at 1 ng/ml (0.7153 0.0520) (Fig. 2) . The expression of ICAM-1 was further increased after co-stimulation with TNFand IL-1 and it became more evident when the dosage of TNFand IL-1 was increased from 100 pg/ml to 500 ng/ml (Table 1) . There was no change of ICAM-1 expression after the addition of human recombinant IFNto TNFand IL-(data not shown).
ICAM-I express ion on mouse MC by P BMC culture s upernata nts and the conce ntration of TNF-a nd ILin s upe rnata nts .
Addition of PBMC culture supernatants into mouse MC induced significantly higher expression of ICAM-1 by s upernatants from the patients with IgA nephropathy compared with that from normal controls (0.4117 0.0202 vs 0.3094 0.0113, P<0.005) (Table 2, Fig. 3 ). ICAM-1 express ion induced by supernatant from IgA nephropathy was higher than that from non-IgA nephropathy (0.3502 0.0249), which was , however, not statistically (P<0.1) significant (Table 2, Fig. 3) .
The concentration of TNF-and IL-1 in the PBMC culture supernatants, meas ured to explain the difference of ICAM-1 expression among the patient groups, was as follows, The concentration of TNFin supernatants from the patient with IgA nephropathy (271.5 43.0 pg/ 100 ) was significantly higher than that from those with non-IgA nephropathy (128.6 17.3 pg/ 100 , P<0.05) and normal controls (96.4 13.9 pg/ 100 , P<0.005) ( Table 2 , Fig. 4) , and that of IL-1 in supernatant from the patients with IgA nephropathy (536 128 pg/ 100 ) was also significantly higher than that from those with non-IgA nephropathy (51.5+18.5 pg/ 100 , P<0.005) and normal controls (43.7 6.6 pg/100 , P<0.005) ( Table 2 , Fig. 5 ).
The ICAM-1 expression induced by PBMC culture supernatant from the patients with IgA nephropathy was significantly correlated with the concentration of TNFand IL-1 in the supernatants (Table 3) . Bes ides stimulating MC proliferation, the cytokines, such as TNF-, IL-1, and IFN-, are known to up-regulate the expression of ICAM-1 in most cells 2 , 4 ) and to induce the MHC class II molecules on APC 1 3 , 1 4 ) . ICAM-1/LFA-1 interaction is known to play a major role in a variety of inflammatory and immune mediated diseases, including allograft rejection and autoimmune disorders, such as systemic lupus erythematosus and multiple sclerosis 5 ,7 , 1 5 ) . However, only a few studies on the role of the ICAM-1 in IgA nephropathy exist . In IgA nephropathy, MC that function as APC may be stimulated by cytokines to express adhes ion molecule such as ICAM-1 and to induce MHC class II molecules 6 ) .
The interaction between MC and T helper cells may develop the immunologic response 7 ) .
Our results on the expression of ICAM-1 on mouse mesangial cells stimulated by human recombinant TNF-, IL-1 and PBMC culture supernatant are in accordance with other studies 2 -4 ) . In brief, ICAM-1 expression is dose-dependently up-regulated in MC by TNFand IL-1 , suggesting that these cytokines may induce ICAM-1 in these cells in vitro, and the effect of PBMC culture supernatant on the up-regulation of ICAM-1 expression may be caused by these cytokines. When the recombinant human TNFand IL-1 and the human PBMC are used as the source of cytokines IL-1 to induce the ICAM-1 expression on mouse MC, amino acid sequence homology and s pecies cross-reactivity between human and murine cytokines s hould be considered l6 , 17 ) . For TNF-, inferred amino acid sequences from human and murine cDNA clones indicate that 79% of the amino acids are conserved between the two species and there are species cross-reactivity between human and mouse. For IL-l , amino acid sequence homology is 62% and human IL-l is also effective in mouse systems. However, murine IFNexhibit only a 40% homology with the human form, and this low degree of homology is believed to contribute to the apparent lack of species crossreactivity. In this study, we can confirm the species cross-reactivity between human and mouse in the aspects of recombinant TNF-, IL-1 , and PBMC culture supernatant on the ICAM-1 expression. We cannot assess the role of IFNon the up-regulation of ICAM-1 in IgA nephropathy because of the species difference. As expected, human recombinant IFNadded at the dosage of 1-500 U to mouse mesangial cells does not s how any effects on ICAM-1 expression (data not shown).
In conclusion, TNF-and IL-l released from mononuclear cells induced the up-regulation of ICAM-1 expression, and this may be related to the immune pathogenesis of IgA nephropathy.
